Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zostavax Is Brand Name For Merck’s Herpes Zoster Vaccine

This article was originally published in The Pink Sheet Daily

Executive Summary

Merck has chosen Zostavax as the brand name for its Phase III herpes zoster vaccine

You may also be interested in...

Merck Plans Pharmaceutical-Style Launch For HPV Vaccine Gardasil

Gardasil's marketing model will be closer to a blockbuster pharmaceutical than to a traditional vaccine, CEO Gilmartin says. The company sees a parallel to the roll-out of Fosamax for osteoporosis.

Time For Independent US FDA? COVID-19 Political Pressure Reignites Debate

The political spotlight on FDA during the COVID-19 pandemic has renewed the long-standing debate as to whether it should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.

Real-World Evidence Uptake Is “Silver Lining” Of COVID-19 Response, USFDA’s Abernethy Says

The coronavirus pandemic highlights the work that is still needed on real-world evidence, agency's principal deputy commissioner says.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts